ASST Sette Laghi (U.O.C. Malattie Infettive e Tropicali)
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Grossi, Paolo
NCT03918798: The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population

Recruiting
2
174
Europe
Chloroprocaine 1% Injectable Solution, ARM 1, Chloroprocaine 2% Injectable Solution, ARM 2
Sintetica SA
Hernia, Inguinal, Flat Foot
12/24
12/24
FORTRESS, NCT02979951: Fosfomycin I.v. for Treatment of Severely Infected Patients

Recruiting
N/A
1000
Europe
Infectopharm Arzneimittel GmbH, INPADS GmbH, Dr. Oestreich + Partner GmbH
Bacterial Infections, Bone Diseases, Infectious, Osteomyelitis, Central Nervous System Bacterial Infections, Meningitis, Bacterial, Encephalitis, Brain Abscess, Urinary Tract Infections, Respiratory Tract Infections, Pneumonia, Bacterial, Skin Diseases, Bacterial, Soft Tissue Infections, Intraabdominal Infections, Sepsis, Bacteremia, Endocarditis, Bacterial
12/30
12/30
NCT05594901: Impact of a Risk Stratification Tool on the Outcome of Liver Transplant Recipients Colonized With Carbapenem Resistant Enterobacteriaceae: an Observational Study

Active, not recruiting
N/A
240
Europe, RoW
Application of a prognostic score
University of Bologna, The Mediterranean Institute for Transplantation and Advanced Specialized Therapies, ASST-Sette Laghi Università degli Studi dell'Insubria Varese, Università degli Studi di Padova Unit Multivisceral Transplant Unit Padova, Università degli Studi di Verona - Gastroenterologia Verona, Hospital General Universitario Gregorio Marañon, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo
Liver Transplantation, Carbapenem-Resistant Enterobacteriaceae Colonization
10/24
06/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Grossi, Paolo
NCT03918798: The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population

Recruiting
2
174
Europe
Chloroprocaine 1% Injectable Solution, ARM 1, Chloroprocaine 2% Injectable Solution, ARM 2
Sintetica SA
Hernia, Inguinal, Flat Foot
12/24
12/24
FORTRESS, NCT02979951: Fosfomycin I.v. for Treatment of Severely Infected Patients

Recruiting
N/A
1000
Europe
Infectopharm Arzneimittel GmbH, INPADS GmbH, Dr. Oestreich + Partner GmbH
Bacterial Infections, Bone Diseases, Infectious, Osteomyelitis, Central Nervous System Bacterial Infections, Meningitis, Bacterial, Encephalitis, Brain Abscess, Urinary Tract Infections, Respiratory Tract Infections, Pneumonia, Bacterial, Skin Diseases, Bacterial, Soft Tissue Infections, Intraabdominal Infections, Sepsis, Bacteremia, Endocarditis, Bacterial
12/30
12/30
NCT05594901: Impact of a Risk Stratification Tool on the Outcome of Liver Transplant Recipients Colonized With Carbapenem Resistant Enterobacteriaceae: an Observational Study

Active, not recruiting
N/A
240
Europe, RoW
Application of a prognostic score
University of Bologna, The Mediterranean Institute for Transplantation and Advanced Specialized Therapies, ASST-Sette Laghi Università degli Studi dell'Insubria Varese, Università degli Studi di Padova Unit Multivisceral Transplant Unit Padova, Università degli Studi di Verona - Gastroenterologia Verona, Hospital General Universitario Gregorio Marañon, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo
Liver Transplantation, Carbapenem-Resistant Enterobacteriaceae Colonization
10/24
06/25

Download Options